Best Laxative for GLP-1 Patients: UK Evidence-Based Guide Constipation is a common side effect of GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), affecting up to 24% of patients
Despite existing psychosocial and pharmacological interventions, available medications are limited and often ineffective for many patients
The "units" marked on the syringe are volume measurements, not dose measurements
If you are prescribed Tirzepatide for type 2 diabetes or chronic weight management, the length of time youll need to stay on this medication will depend on several personal factorsincluding your specific health goals, how your body responds to treatment, and ongoing recommendations from your provider
Clinical trials have demonstrated substantial reductions in hemoglobin A1c levels (often 1.5-2.5 percentage points, depending on dose) and significant weight loss (approximately 5-20% of baseline body weight, with higher percentages generally seen in non-diabetic populations with obesity)
